• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Long-term toxicity of early stages of Hodgkin's disease therapy: the EORTC experience. EORTC Lymphoma Cooperative Group.

作者信息

Cosset J M, Henry-Amar M, Meerwaldt J H

机构信息

Radiotherapy Department and INSERM U247, Institut Gustave-Roussy, Villejuif, France.

出版信息

Ann Oncol. 1991 Feb;2 Suppl 2:77-82. doi: 10.1093/annonc/2.suppl_2.77.

DOI:10.1093/annonc/2.suppl_2.77
PMID:2049323
Abstract
摘要

相似文献

1
Long-term toxicity of early stages of Hodgkin's disease therapy: the EORTC experience. EORTC Lymphoma Cooperative Group.霍奇金淋巴瘤治疗早期的长期毒性：欧洲癌症研究与治疗组织（EORTC）的经验。EORTC淋巴瘤协作组
Ann Oncol. 1991 Feb;2 Suppl 2:77-82. doi: 10.1093/annonc/2.suppl_2.77.
2
A prospective clinical trial comparing chemotherapy, radiotherapy and combined therapy in the treatment of early stage Hodgkin's disease with bulky disease.一项比较化疗、放疗及联合治疗早期伴有巨大肿块的霍奇金病的前瞻性临床试验。
Clin Lab Haematol. 1998 Apr;20(2):95-9. doi: 10.1046/j.1365-2257.1998.00096.x.
3
Second neoplasms in patients with Hodgkin's disease following combined modality therapy--the Yale experience.霍奇金淋巴瘤患者综合治疗后的第二原发性肿瘤——耶鲁大学的经验
J Clin Oncol. 1986 Mar;4(3):311-7. doi: 10.1200/JCO.1986.4.3.311.
4
Randomized comparison of ABVD chemotherapy with a strategy that includes radiation therapy in patients with limited-stage Hodgkin's lymphoma: National Cancer Institute of Canada Clinical Trials Group and the Eastern Cooperative Oncology Group.局限期霍奇金淋巴瘤患者中ABVD化疗与包含放射治疗策略的随机对照研究：加拿大国立癌症研究所临床试验组和东部肿瘤协作组
J Clin Oncol. 2005 Jul 20;23(21):4634-42. doi: 10.1200/JCO.2005.09.085. Epub 2005 Apr 18.
5
Thyroid, pulmonary, and cardiac sequelae after treatment for Hodgkin's disease.霍奇金淋巴瘤治疗后的甲状腺、肺部及心脏后遗症。
Ann Oncol. 1992 Sep;3 Suppl 4:111-5. doi: 10.1093/annonc/3.suppl_4.s111.
6
[Incidence and significance of therapy-associated late toxicity in Hodgkin's disease].[霍奇金淋巴瘤治疗相关晚期毒性的发生率及意义]
Dtsch Med Wochenschr. 1995 Aug 4;120(31-32):1093-9. doi: 10.1055/s-2008-1055450.
7
Concomitant illness in patients treated for Hodgkin's disease.接受霍奇金病治疗患者的伴发疾病
Cancer Treat Rev. 1986 Jun;13(2):77-111. doi: 10.1016/0305-7372(86)90015-0.
8
An affair of the heart.一件与心脏有关的事。 （不过更常见的意思是“一段感情纠葛” ）
J Natl Cancer Inst. 2007 Feb 7;99(3):186-7. doi: 10.1093/jnci/djk058.
9
Management of relapse and survival in advanced stage Hodgkin's disease: the EORTC experience.
Ann Oncol. 1991 Feb;2 Suppl 2:63-6. doi: 10.1007/978-1-4899-7305-4_10.
10
Treatment options in early stages of Hodgkin's Lymphoma, high cure rate with lower short and long-term toxicity.
Hematology. 2005;10 Suppl 1:3-5. doi: 10.1080/10245330512331389700.

引用本文的文献

1
Modelling recurrence and second cancer risks induced by proton therapy.质子治疗引发的复发和二次癌症风险建模。
Math Med Biol. 2018 Sep 11;35(3):347-361. doi: 10.1093/imammb/dqx006.
2
Chemotherapy and Radiation Induced Pulmonary Dysfunction in Hodgkin Lymphoma Patients.霍奇金淋巴瘤患者化疗和放疗所致的肺功能障碍
Indian J Hematol Blood Transfus. 2016 Dec;32(4):431-436. doi: 10.1007/s12288-015-0619-x. Epub 2015 Nov 14.
3
[IF-RT alone remains gold standard for stage IA nodular lymphocyte-predominant Hodgkin lymphoma].对于ⅠA期结节性淋巴细胞为主型霍奇金淋巴瘤，单纯受累野放疗仍是金标准。
Strahlenther Onkol. 2016 Jun;192(6):428-30. doi: 10.1007/s00066-016-0975-y.
4
Pregnancy-associated cardiomyopathy in survivors of childhood cancer.儿童癌症幸存者中的妊娠相关心肌病
J Cancer Surviv. 2016 Feb;10(1):113-21. doi: 10.1007/s11764-015-0457-8. Epub 2015 Jun 5.
5
Secondary cancer in a survivor of Hodgkin's lymphoma: A case report and review of the literature.霍奇金淋巴瘤幸存者的继发性癌症：一例病例报告及文献综述
Oncol Lett. 2015 Feb;9(2):964-966. doi: 10.3892/ol.2014.2799. Epub 2014 Dec 12.
6
Risk of second malignancies in patients with early-stage classical Hodgkin's lymphoma treated in a modern era.现代治疗的早期经典型霍奇金淋巴瘤患者发生第二原发恶性肿瘤的风险
Cancer Med. 2015 Apr;4(4):513-8. doi: 10.1002/cam4.405. Epub 2015 Jan 26.
7
Efficacy of dose escalation on TCP, recurrence and second cancer risks: a mathematical study.剂量递增对肿瘤控制概率、复发及二次癌症风险的疗效：一项数学研究。
Br J Radiol. 2014 Nov;87(1043):20140377. doi: 10.1259/bjr.20140377. Epub 2014 Sep 11.
8
Role of Radiotherapy in Modern Treatment of Hodgkin's Lymphoma.放射治疗在霍奇金淋巴瘤现代治疗中的作用
Adv Hematol. 2011;2011:258797. doi: 10.1155/2011/258797. Epub 2010 Oct 24.
9
Nodular lymphocyte-predominant Hodgkin's lymphoma.结节性淋巴细胞为主型霍奇金淋巴瘤。
Curr Hematol Malig Rep. 2006 Mar;1(1):60-5. doi: 10.1007/s11899-006-0019-2.
10
Nodular lymphocyte predominant Hodgkin lymphoma (NLPHL)-clinicopathological features based on the data of two Hungarian lymphoma centres.基于两个匈牙利淋巴瘤中心数据的结节性淋巴细胞为主型霍奇金淋巴瘤（NLPHL）的临床病理特征
Pathol Oncol Res. 2008 Dec;14(4):411-21. doi: 10.1007/s12253-008-9043-y. Epub 2008 Apr 23.